Menu
Back to Journals » Transplant Research and Risk Management
Transplant Research and Risk Management
- View all (72)
- Volume 11, 2019 (6)
- Volume 10, 2018 (1)
- Volume 9, 2017 (7)
- Volume 8, 2016 (5)
- Volume 7, 2015 (8)
- Volume 6, 2014 (12)
- Volume 5 , 2013 (3)
- Volume 4, 2012 (5)
- Volume 3, 2011 (10)
- Volume 2, 2010 (13)
- Volume 1, 2009 (2)
Journal Articles:
- 72 records -
BK virus in transplant recipients: current perspectives
Muhsin SA, Wojciechowski D
Transplant Research and Risk Management 2019, 11:47-58
Published Date: 9 September 2019
Public attitudes toward vascularized composite allograft donation: a literature review
Kaur M, Thoma A
Transplant Research and Risk Management 2019, 11:39-46
Published Date: 3 September 2019
Pregnancy in heart transplant recipients – current perspectives
Watson WD, Bhagra SK, Bhagra CJ
Transplant Research and Risk Management 2019, 11:29-38
Published Date: 23 August 2019
Circulating nucleic acids as biomarkers for allograft injury after solid organ transplantation: current state-of-the-art
Pattar SK, Greenway SC
Transplant Research and Risk Management 2019, 11:17-27
Published Date: 27 June 2019
Regeneration of trabecular meshwork in primary open angle glaucoma by stem cell therapy: a new treatment approach
Vingolo EM, Chabib A, Anselmucci F
Transplant Research and Risk Management 2019, 11:11-16
Published Date: 3 April 2019
Effect of pretransplant depression on neutrophil recovery following hematopoietic stem cell transplantation
Tavakoli-Ardakani M, Beyraghi N, Mirjalili M, Mirzaei E, Mehrpooya M
Transplant Research and Risk Management 2019, 11:1-9
Published Date: 4 April 2019
Microbiome alterations following solid-organ transplantation: consequences, solutions, and prevention
Rahim HP, Taylor MR, Hirota SA, Greenway SC
Transplant Research and Risk Management 2018, 10:1-11
Published Date: 6 April 2018
One-year survival rate of renal transplant: factors influencing the outcome
Rezapour S, Yarmohammadi A, Tavakkoli M
Transplant Research and Risk Management 2017, 9:49-56
Published Date: 15 December 2017
Efficacy of everolimus in ABO-incompatible kidney transplantation: a retrospective study
Tsujimura K, Ota M, Chinen K, Nagayama K, Oroku M, Nishihira M, Shiohira Y, Iseki K, Ishida H, Tanabe K
Transplant Research and Risk Management 2017, 9:43-48
Published Date: 27 September 2017
Response to “Hand transplantation: current challenges and future prospects”
Trofe-Clark J, Levin LS
Transplant Research and Risk Management 2017, 9:39-41
Published Date: 6 July 2017
Association of depression and anxiety before heart transplant with mortality after transplant: a single-center experience
Epstein F, Parker MM, Lucero A, Chaudhary R, Song E, Weisshaar D
Transplant Research and Risk Management 2017, 9:31-38
Published Date: 24 March 2017
Hand transplantation: current challenges and future prospects
Alolabi N, Augustine H, Thoma A
Transplant Research and Risk Management 2017, 9:23-29
Published Date: 21 February 2017
Urinary neutrophil gelatinase-associated lipocalin is a biomarker of delayed graft function after kidney transplantation
Capelli I, Baraldi O, Comai G, Sala E, Cappuccilli M, Donadei C, Cuna V, Angelini ML, Donati G, La Manna G
Transplant Research and Risk Management 2017, 9:15-21
Published Date: 20 January 2017
Risk factors, diagnosis, and management of posttransplant lymphoproliferative disorder: improving patient outcomes with a multidisciplinary treatment approach
Ligeti K, Müller LP, Müller-Tidow C, Weber T
Transplant Research and Risk Management 2017, 9:1-14
Published Date: 27 January 2017
Is portal vein thrombosis still a contraindication for liver transplantation? A single-institute’s 5-year experience and literature review
Ghazwani S, Panaro F, Navarro F
Transplant Research and Risk Management 2016, 8:31-36
Published Date: 18 November 2016
Current perspectives in transplant medicine: hypothermic oxygenated perfusion
Michel SG, Madsen JC
Transplant Research and Risk Management 2016, 8:25-30
Published Date: 10 November 2016
Psychological rejection of the transplanted organ and graft dysfunction in kidney transplant patients
Látos M, Lázár G, Horváth Z, Wittmann V, Szederkényi E, Hódi Z, Szenohradszky P, Csabai M
Transplant Research and Risk Management 2016, 8:15-24
Published Date: 29 June 2016
Tumor-resected kidney transplant – a quality of life survey
Sundararajan S, He B, Delriviere L
Transplant Research and Risk Management 2016, 8:9-13
Published Date: 2 May 2016
Machine perfusion for improving outcomes following renal transplant: current perspectives
Cannon RM, Franklin GA
Transplant Research and Risk Management 2016, 8:1-7
Published Date: 29 March 2016
Transplant surgery and the obese patient: special considerations
Mohan P, Kadian M, Srinivas TR
Transplant Research and Risk Management 2015, 7:71-81
Published Date: 4 December 2015
Drugs in development for prophylaxis of rejection in kidney-transplant recipients
Sanders ML, Langone AJ
Transplant Research and Risk Management 2015, 7:59-69
Published Date: 18 August 2015
Psychosocial challenges before and after organ transplantation
Schulz KH, Kroencke S
Transplant Research and Risk Management 2015, 7:45-58
Published Date: 4 August 2015
Preoperative psychological evaluation of transplant patients: challenges and solutions
Kumnig M, Jowsey-Gregoire S
Transplant Research and Risk Management 2015, 7:35-43
Published Date: 26 June 2015
Nonadherence to immunosuppression: challenges and solutions
Moreso F, Torres IB, Costa-Requena G, Serón D
Transplant Research and Risk Management 2015, 7:27-34
Published Date: 3 June 2015
Hyperosmolar nonketotic hyperglycemic coma induced by methylprednisolone pulse therapy for acute rejection after liver transplantation: a case report and review of the literature
Zhou J, Ju W, Yuan X, Zhu X, Wang D, He X
Transplant Research and Risk Management 2015, 7:23-26
Published Date: 22 December 2014
Cardiac allograft immune activation: current perspectives
Chang D, Kobashigawa J
Transplant Research and Risk Management 2015, 7:13-22
Published Date: 18 December 2014
Organizational determinants in the procurement and transplantation pathway: a review
Triassi M, Giancotti E, Nardone A, Mancini G, Rubba F
Transplant Research and Risk Management 2015, 7:1-12
Published Date: 17 December 2014
Transplant coronary heart disease: challenges and solutions
Jentzer JC, Hickey GW, Khandhar SJ
Transplant Research and Risk Management 2014, 6:117-127
Published Date: 11 December 2014
Current perspectives on antibody-mediated rejection after lung transplantation
Witt CA, Hachem RR
Transplant Research and Risk Management 2014, 6:109-115
Published Date: 8 October 2014
Transplantation in highly HLA-sensitized patients: challenges and solutions
Kim IK, Vo A, Jordan SC
Transplant Research and Risk Management 2014, 6:99-107
Published Date: 26 September 2014
Chronic lung allograft dysfunction following lung transplantation: challenges and solutions
Bemiss BC, Witt CA
Transplant Research and Risk Management 2014, 6:87-97
Published Date: 25 September 2014
Potential for clinical pancreatic islet xenotransplantation
Bottino R, Nagaraju S, Satyananda V, Hara H, Wijkstrom M, Trucco M, Cooper DKC
Transplant Research and Risk Management 2014, 6:79-86
Published Date: 24 September 2014
Triple antiviral therapy with telaprevir after liver transplantation: a case series
Knapstein J, Grimm D, Wörns MA, Galle PR, Lang H, Zimmermann T
Transplant Research and Risk Management 2014, 6:73-78
Published Date: 9 September 2014
Prevention of organ rejection in renal and liver transplantation with extended release tacrolimus
Reschen ME, O'Callaghan CA
Transplant Research and Risk Management 2014, 6:55-72
Published Date: 2 September 2014
Management of Candida infections in liver transplant recipients: current perspectives
Lingegowda PB, Tan BH
Transplant Research and Risk Management 2014, 6:45-53
Published Date: 7 July 2014
The role of mTOR inhibitors in the prevention of organ rejection in adult liver transplant patients: a focus on everolimus
Casanovas T
Transplant Research and Risk Management 2014, 6:31-43
Published Date: 24 June 2014
Next-generation calcineurin inhibitors in development for the prevention of organ rejection
Gheith O, Al-Otaibi T, Mansour H
Transplant Research and Risk Management 2014, 6:23-30
Published Date: 25 March 2014
Rabbit anti-thymocyte globulin induction in renal transplantation: review of the literature
Andress L, Gupta A, Siddiqi N, Marfo K
Transplant Research and Risk Management 2014, 6:9-21
Published Date: 15 January 2014
Heart transplantation and arterial elasticity
Colvin-Adams M, Harcourt N, LeDuc R, Raveendran G, Sonbol Y, Wilson R, Duprez D
Transplant Research and Risk Management 2014, 6:1-7
Published Date: 23 December 2013
Update on laparoscopic/robotic kidney transplant: a literature review
He B, Hamdorf JM
Transplant Research and Risk Management 2013, 5:33-39
Published Date: 9 September 2013
Pediatric kidney transplantation: a review
Sharma A, Ramanathan R, Posner M, Fisher RA
Transplant Research and Risk Management 2013, 5:21-31
Published Date: 16 July 2013
Lung transplantation for chronic obstructive pulmonary disease
Liou TG, Raman SM, Cahill BC
Transplant Research and Risk Management 2013, 5:1-20
Published Date: 4 July 2013
Appraisal of donor steatosis in liver transplantation: a survey of current practice in Australia and New Zealand
Dare AJ, Phillips AR, Chu M, Hickey AJ, Bartlett AS
Transplant Research and Risk Management 2012, 4:31-37
Published Date: 14 December 2012
Retrospective review of bone mineral metabolism management in end-stage renal disease patients wait-listed for renal transplant
Chavlovski A, Knoll GA, Ramsay T, Hiremath S, Zimmerman DL
Transplant Research and Risk Management 2012, 4:25-30
Published Date: 5 September 2012
The value of prophylactic vaccinations and antibiotic treatment in post-splenectomy patients: a review
Lammers AJ
Transplant Research and Risk Management 2012, 4:19-24
Published Date: 28 June 2012
Potential benefits and risks of clinical xenotransplantation
Cooper DKC, Ayares D
Transplant Research and Risk Management 2012, 4:7-17
Published Date: 3 July 2012
Sirolimus-associated hepatotoxicity: case report and review of the literature
Macdonald B, Vakiani E, Yantiss RK, Lee J, Brown RS Jr, Sigal SH
Transplant Research and Risk Management 2012, 4:1-5
Published Date: 18 January 2012
Facial transplantation: a review of ethics, progress, and future targets
Edwards JA, Mathes DW
Transplant Research and Risk Management 2011, 3:113-125
Published Date: 5 September 2011
Everolimus in kidney transplantation
Cooper JE, Christians U, Wiseman AC
Transplant Research and Risk Management 2011, 3:97-112
Published Date: 8 July 2011
Evaluation of medication errors via a computerized physician order entry system in an inpatient renal transplant unit
Marfo K, Garcia D, Khalique S, Berger K, Lu A
Transplant Research and Risk Management 2011, 3:91-96
Published Date: 18 May 2011
Long-term outcome of everolimus treatment in transplant patients
Salvadori M, Bertoni E
Transplant Research and Risk Management 2011, 3:77-90
Published Date: 13 May 2011
Critical appraisal of belatacept for prophylaxis of rejection in kidney transplant patients
Martin ST, Tsapepas D, Gabardi S, Chandraker A
Transplant Research and Risk Management 2011, 3:65-75
Published Date: 12 April 2011
Development and utility of pirfenidone in the treatment of idiopathic pulmonary fibrosis: review of preclinical science and recent clinical trials
Jackson RM, Gomez-Marin O
Transplant Research and Risk Management 2011, 3:55-63
Published Date: 11 April 2011
Mycophenolic acid agents: is enteric coating the answer?
Manitpisitkul W, Lee S, Cooper M
Transplant Research and Risk Management 2011, 3:45-53
Published Date: 29 March 2011
Pathophysiology, prevention, and treatment of acute graft-versus-host disease
Abhinav Deol, Voravit Ratanatharathorn, Joseph P Uberti
Transplant Research and Risk Management 2011, 3:31-44
Published Date: 7 March 2011
Impact of everolimus: update on immunosuppressive therapy strategies and patient outcomes after renal transplantation
Helio Tedesco-Silva Jr, Claudia Rosso Felipe, Tainá Veras de Sandes Freitas, et al
Transplant Research and Risk Management 2011, 3:9-29
Published Date: 24 January 2011
Human amniotic membrane, best healing accelerator, and the choice of bone induction for vestibuloplasty technique (an animal study)
Mohammad H Samandari, Shahriar Adibi, Ahad Khoshzaban, et al
Transplant Research and Risk Management 2011, 3:1-8
Published Date: 22 December 2010
Ethical issues in kidney transplantation – reflections from Nigeria
Joseph Olusesan Fadare, Babatunde L Salako
Transplant Research and Risk Management 2010, 2:87-91
Published Date: 19 November 2010
Delayed hyperacute rejection in a patient who developed clostridium difficile infection after ABO-incompatible kidney transplantation
Gerald S Lipshutz, Elaine F Reed, Phuong-Chi Pham, et al
Transplant Research and Risk Management 2010, 2:81-85
Published Date: 8 November 2010
Assessing the safety and quality of ward-based renal transplant biopsies
Kenneth Wu, Bindhu Musunuru, Chera Arunachalam, et al
Transplant Research and Risk Management 2010, 2:77-79
Published Date: 7 October 2010
Eleven years of management of children with intestinal failure and not candidates for intestinal transplantation
MI Spagnuolo, MP Cicalese, E Bruzzese, et al.
Transplant Research and Risk Management 2010, 2:71-75
Published Date: 1 September 2010
Role of tacrolimus prolonged release in the prevention of allograft rejection
Peter Abrams, Abhinav Humar, Henkie P Tan
Transplant Research and Risk Management 2010, 2:65-70
Published Date: 9 August 2010
Knowledge and level of awareness of renal transplantation among medical students in Nigeria
Augustine O Takure, Sylvester O Alikah, Vincent C Onuora
Transplant Research and Risk Management 2010, 2:59-64
Published Date: 22 July 2010
Clinical use of plerixafor in combination with granulocyte-colony stimulating factor in hematopoietic stem cell transplantation
Cedar J Fowler, Richard T Maziarz
Transplant Research and Risk Management 2010, 2:47-58
Published Date: 11 May 2010
Liver transplantation in Egypt from West to East
Galal H El-Gazzaz, Azza H El-Elemi
Transplant Research and Risk Management 2010, 2:41-46
Published Date: 7 April 2010
Valganciclovir for the prophylaxis and treatment of cytomegalovirus infection in solid organ transplantation
Erin Wade Ticehurst, Jennifer Trofe-Clark, Emily Blumberg, et al
Transplant Research and Risk Management 2010, 2:29-39
Published Date: 30 March 2010
Moving towards implementation of a clinical ethics consultation program in Egyptian liver transplant units
A H El-Elemi, G H El-Gazzaz
Transplant Research and Risk Management 2010, 2:23-27
Published Date: 16 March 2010
Low antigenicity of hematopoietic progenitor cells derived from human ES cells
Eun-Mi Kim, Nicholas Zavazava
Transplant Research and Risk Management 2010, 2:15-22
Published Date: 3 February 2010
Critical appraisal on the use of everolimus in renal transplantation as an immunosuppressant to prevent organ transplant rejection
Fernando Giron, Yenny Baez
Transplant Research and Risk Management 2010, 2:11-14
Published Date: 21 January 2010
Optimizing use of basiliximab in liver transplantation
Carlo B Ramirez, Adam Bozdin, Adam Frank, et al
Transplant Research and Risk Management 2010, 2:1-10
Published Date: 6 January 2010
Rituximab: An emerging therapeutic agent for kidney transplantation
Joseph Kahwaji, Chris Tong, Stanley C Jordan, et al
Transplant Research and Risk Management 2009, 1:15-29
Published Date: 19 October 2009
Managing hepatitis C in liver transplant patients with recurrent infection
Tim Zimmermann, Gerd Otto, Marcus Schuchmann
Transplant Research and Risk Management 2009, 1:1-14
Published Date: 13 September 2009